1028 / 1096
S1012
ESTRO 36
_______________________________________________________________________________________________
Results
Two hundred and four male patients were invited and
agreed to participate the study. The median age was 53.9
(30-74). Ninety four (46.1%) patients had buccal cancer,
46 nasopharyngeal cancer, 46 oro-hypopharyngeal cancer
and 12 laryngeal cancer. One hundred and thirty (63.7%)
patients had previous betal
quid chewing and 109
(53.4%)
had alcohol drinking. One hundred and three patients had
surgery, 191 chemotherapy and all had radiotherapy.
Thirty four (16.7%) patients had no religion belief and 30
(14.7%) had no job at interview. Sixty two (30.4%) patients
had continuing smoking, 18 (8.8%) patients continued
drinking and 6 (2.9%) betal quid chewing. Several
relationships had been found after analysis. The presence
of meaning had positive effect on global quality of life,
emotional well-being and total quality of life.
Furthermore, the low presence of meaning and high
search for meaning exhibited the lowest levels of general
quality of life, emotional well-being and total quality of
life. The presence of meaning has negative effect on
emotional distress. Furthermore the low presence of
meaning and high search for meaning exhibited the
highest levels of emotional distress. The longer duration
of smoking had less levels of presence of meaning and
search for meaning.
Conclusion
Individuals in the high presence of meaning showed a
better adaptation. Compared to those survivors having low
presence and low searching for meaning, the head and
neck cancer survivors having low presence of meaning and
high searching for meaning would have the most poorly
emotional
distress
and
quality
of
life.
EP-1851 Why is planned palliative radiotherapy often
cancelled? A retrospective exploratory study
H. Hansen
1
, M. Skovhus Thomsen
2
1
Aarhus University Hospital, Clinic for Radiotherapy and
Radiation Oncology, Aarhus C, Denmark
2
Aarhus University Hospital, Department of Medical
Physics, Aarhus C, Denmark
Purpose or Objective
In our department all appointments are booked when the
referral is received, i.e. a 100% pre-booking is performed.
In 2014-15 every 7th treatment course for patients
referred and booked to palliative treatment in our
department was cancelled before the planned start of
radiotherapy. This study investigated the reasons for
cancellations of palliative treatment courses prior to start
of radiotherapy as well as possible common denominators
among the cancelled patients
.
Material and Methods
A retrospective exploratory study of reasons for cancelling
planned palliative radiotherapy treatment was
established. Patients were included if they had been
booked for palliative radiotherapy treatment between
1January 2015 and 30 June 2015. Two sets of data were
collected. Firstly, data on age, gender and diagnosis was
collected on all planned palliative radiotherapy
treatments (n =787). Secondly, data on all patients who
had been cancelled before planned start of treatment
(n=105) was obtained. Data on cancelled patients included
demographic and clinical data as well as other relevant
data recorded in the time between referral to palliative
radiotherapy and cancellation. If a patient had been
cancelled more than once during the study period data
was only collected on the first cancellation.
Results
Of the 787 planned radiotherapy courses, 106 (13 %)
courses were cancelled before planned start of treatment.
Of the 106 courses cancelled, one patient accounted for
two cancelled treatments. The median time between
referral and planned start of treatment for the cancelled
courses was 14 days, showing that the majority of
cancelled patients were planned to start radiotherapy
much earlier than the maximum time limit of 28 days
specified
in
the
Danish
legislation.
Results of data collected on all planned palliative
radiotherapy treatments showed that patients' age,
gender and diagnosis did not differ between the courses
cancelled before planned start and courses started.
Main reasons for cancellation were death before start of
treatment, the patient being too weak to start treatment
or treatment was no longer relevant. Five of the 33
patients cancelled because they were too weak to receive
palliative radiotherapy, died in the time interval between
cancellation and the day they were supposed to start
treatment. The total number of patients who died before
planned start of treatment was 29 (28 %) (Table1).
Conclusion
The main reasons for cancelling palliative radiotherapy
were the patient either being too weak to receive
treatment/ dying before beginning of treatment or
because treatment was no longer relevant. The other data
collected could not explain the number of patients being
cancelled. More knowledge is needed about the
differences between patients starting palliative
radiotherapy treatment and patients being cancelled
before start of
treatment.
EP-1852 A research interventional clinic within the NHS
to enable participation in prostate clinical trials
K. Crowther
1
, A. O'Neill
1,2
, S. Murray
3
, J. Cousins
3
, O.
Stewart
3
, G. Totten
3
, S. Hynds
3
, K. Parsons
3
, P. Shiels
1
, C.
Logan
1
, D. Mitchell
1
, C. Lyons
1
, S. Jain
1,2
1
Cancer Centre- Belfast City Hospital, Radiotherapy,
Belfast, United Kingdom
2
Centre for Cancer Research and Cell Biology, Queen's
University, Belfast, United Kingdom
3
Belfast City Hospital, Northern Ireland Cancer Trials
Network, Belfast, United Kingdom
Purpose or Objective
Within prostate cancer clinical trials there has been an
increasing move towards hypo-fractionated and
Stereotactic Ablative Radiotherapy (SABR) regimes. This
has led to an increased requirement for Image-Guided
Radiotherapy (IGRT). At our centre, it was therefore
necessary to implement a service to facilitate the
implanting of fiducial markers (FM) and other
interventional procedures to enable our participation in
such clinical trials.
Material and Methods
Funding for this service was secured from a research
grant. A multi-disciplinary working group of Consultant
Clinical
Oncologists,
Radiographers,
Hospital
Management, Nurses, Clinical Trials team and Clinical
Research Fellows was formed. This group ensured the